Clinical Trials in Austin

Showing 14101-14120 of 15,205 trials

Multidisciplinary Approach to Reduce Injury and Alcohol

NCT00428181

The purpose of this study is to determine whether a booster session is needed after a brief intervention upon initial admission to the emergency room (ER) in order to reduce the rate of alcohol-related injury recidivism.

Drinking BehaviorInjury Recidivism

University of Texas at Austin605 participantsStarted Sep 2007

Austin, Texas, United States • Dallas, Texas, United States • Dallas, Texas, United States

COMPLETEDPhase 1/2< 1 mile

A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)

NCT00932074

The purpose of this study is to assess the safety, tolerability and efficacy of KP-413 topical ointment compared with vehicle ointment in treating adult subjects with atopic dermatitis (AD).

Atopic Dermatitis

Kaken Pharmaceutical58 participantsStarted Jul 2009

Clinton Twp., Michigan, United States • Portland, Oregon, United States • Austin, Texas, United States +3 more locations

COMPLETEDPhase 474 miles

Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program

NCT00401726

The purpose of this study is to evaluate the effect of the Dialogues Time to Talk program in subjects treated with Venlafaxine Extended Release (ER). Dialogues Time to Talk Program is a patient management program, which aims to help patients achieve successful outcomes by reinforcing physician treatment efforts, providing feedback to treating physicians, and encouraging better physician-patient communications.

Depressive Disorder, Major

Wyeth is now a wholly owned subsidiary of Pfizer537 participantsStarted Jun 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mesa, Arizona, United States +41 more locations

Multidisciplinary Approach to Reduce Injury and Alcohol

A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)

Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program

Find Trials by Condition in Austin

Safety Study of BMS-770767 in Subjects With Hypercholesterolemia

Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis

Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders

Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme

Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects

A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects

AZD7268 Safety and Tolerability Study

The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder

Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms

A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

A Study in the Treatment of Osteoarthritis Knee Pain

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis